摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(3-溴苯基)-1H-吡咯-2,5-二酮 | 53534-14-8

中文名称
1-(3-溴苯基)-1H-吡咯-2,5-二酮
中文别名
1-(3-溴苯基)-2,5-二氢-1H-吡咯-2,5-二酮;N-(3-溴苯基)马来酰亚胺
英文名称
N-(3-bromophenyl)maleimide
英文别名
N-(m-Bromphenyl)-maleinimid;1-(3-bromophenyl)-1H-pyrrole-2,5-dione;1-(3-bromophenyl)pyrrole-2,5-dione
1-(3-溴苯基)-1H-吡咯-2,5-二酮化学式
CAS
53534-14-8
化学式
C10H6BrNO2
mdl
MFCD00175233
分子量
252.067
InChiKey
KJJYDECLTBAKCK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    114-116 °C
  • 沸点:
    368.0±25.0 °C(Predicted)
  • 密度:
    1.721±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    37.4
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 危险品标志:
    Xi
  • 海关编码:
    2925190090
  • 储存条件:
    室温

SDS

SDS:355e030d2f04f20ce40c1f1be1cc52bd
查看
Material Safety Data Sheet

Section 1. Identification of the substance
1-(3-Bromophenyl)pyrrole-2,5-dione
Product Name:
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

Section 3. Composition/information on ingredients.
1-(3-Bromophenyl)pyrrole-2,5-dione
Ingredient name:
CAS number: 53534-14-8

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C10H6BrNO2
Molecular weight: 252.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(3-溴苯基)-1H-吡咯-2,5-二酮异丁醛 在 C26H43N3OS 作用下, 以 甲苯 为溶剂, 以72%的产率得到2-(1-(3-bromophenyl)-2,5-dioxopyrrolidin-3-yl)-2-methylpropanal
    参考文献:
    名称:
    新型双萜衍生的双功能硫脲催化剂促进的高对映选择性迈克尔加成反应:手性琥珀酰亚胺衍生物的双立体控制方法
    摘要:
    描述了双立体控制的有机催化不对称迈克尔加成取代琥珀酰亚胺的合成。从醛和马来酰亚胺开始,将两种特殊的手性双萜衍生的双官能硫脲分别用作丁二酰亚胺时,琥珀酰亚胺的两种对映异构体均可以高至优异的收率(高达98%)和对映选择性(高达99%)获得。催化剂。而且,这些催化剂可以有效地用于大规模催化合成,且产率和对映选择性相同。手性00:000–000,2014年。©2014 Wiley Periodicals,Inc.
    DOI:
    10.1002/chir.22279
  • 作为产物:
    参考文献:
    名称:
    使用平面手性 [2.2] 对环芳烷-咪唑啉 N,O-配体对偶氮甲碱叶立德进行锌催化的对映选择性 [3+2] 环加成
    摘要:
    已经开发了一种简便的合成路线,制备一系列具有中心手性和平面手性的新型 [2.2] 对环芳烃衍生配体 (UCD-IMPHANOL)。这些配体在不对称 Zn 催化的偶氮甲碱叶立德环加成反应中表现出优异的对映选择性。
    DOI:
    10.1002/anie.202205516
点击查看最新优质反应信息

文献信息

  • Isatin <i>N</i>,<i>N</i>′-Cyclic Azomethine Imine 1,3-Dipole and Abnormal [3 + 2]-Cycloaddition with Maleimide in the Presence of 1,4-Diazabicyclo[2.2.2]octane
    作者:Xiao Wang、Peng Yang、Yong Zhang、Chao-Zhe Tang、Fang Tian、Lin Peng、Li-Xin Wang
    DOI:10.1021/acs.orglett.6b03815
    日期:2017.2.3
    A new isatin N,N′-cyclic azomethine imine synthon was devised, and an unexpected abnormal [3 + 2]-cycloaddition with maleimide catalyzed by 1,4-diazabicyclo[2.2.2]octane (DABCO) has been disclosed. A variety of tricyclic spiropyrrolidine oxindoles bearing a dinitrogen heterocycle and succinimide scaffold were obtained in excellent yields (up to 96%) and diastereoselectivities (up to 97:3) under mild
    设计了一种新的Isatin N,N'-环甲亚胺亚胺合子,并公开了1,4-二氮杂双环[2.2.2]辛烷(DABCO)催化的马来酰亚胺意外异常[3 + 2]-环加成反应。在温和条件下,以优异的收率(高达96%)和非对映选择性(高达97:3)获得了多种带有二氮杂环和琥珀酰亚胺支架的三环螺吡咯烷恶唑。
  • Synthesis and in Vitro Evaluation of N-Substituted Maleimide Derivatives as Selective Monoglyceride Lipase Inhibitors
    作者:Nicolas Matuszak、Giulio G. Muccioli、Geoffray Labar、Didier M. Lambert
    DOI:10.1021/jm900461w
    日期:2009.12.10
    action is quickly terminated via enzymatic hydrolysis catalyzed by monoglyceride lipase (MGL). Regulating its endogenous level could offer therapeutic opportunities; however, few selective MGL inhibitors have been described so far. Here, we describe the synthesis of N-substituted maleimides and their pharmacological evaluation on the recombinant human fatty acid amide hydrolase (FAAH) and on the purified
    内源性大麻素2-花生四烯酸甘油酯(2-AG)在许多生理过程中起着重要作用,其作用通过甘油单酯脂肪酶(MGL)催化的酶促水解迅速终止。调节其内源水平可以提供治疗机会;然而,到目前为止,几乎没有描述选择性的MGL抑制剂。在这里,我们描述了N-取代的马来酰亚胺的合成及其对重组人脂肪酸酰胺水解酶(FAAH)和纯化人MGL的药理评价。先前已经描述了一些N-芳基马来酰亚胺(萨里奥(SM);萨洛(OM);Nevalainen,T .;Poso,A。莱蒂宁(JT);贾文恩(T. Jarvinen)Niemi,R.大鼠小脑膜中2-花生四烯酸甘油水解酶中巯基敏感位点的表征。化学 生物学 2005年,12,649-656),为MGL抑制剂,以及沿着这些线路,我们提出一组新的马来酰亚胺衍生物的那显示出低微摩尔的IC 50和朝向MGL VS FAAH高选择性。然后,研究了结构活性关系,例如,1-biphenyl-4
  • Substituent chemical shifts of<i>N</i>-arylsuccinanilic acids,<i>N</i>-arylsuccinimides,<i>N</i>-arylmaleanilic acids, and<i>N</i>-arylmaleimides
    作者:Hye Sun Lee、Ji Sook Yu、Chang Kiu Lee
    DOI:10.1002/mrc.2450
    日期:2009.9
    NMR spectra of a series of N-arylsuccinanilic acids, N-arylsuccinimides, N-arylmaleanilic acids, and N-arylmaleimides were examined to estimate the electronic effect of the amide and imide groups on the chemical shifts of the hydrogen and carbon nuclei of the benzene ring.
    检查了一系列N-芳基琥珀酸,N-芳基琥珀酰亚胺,N-芳基马来酸和N-芳基马来酰亚胺的NMR光谱,以评估酰胺基和酰亚胺基对苯的氢和碳核化学位移的电子影响戒指。
  • Organocatalytic asymmetric conjugate addition of α-substituted cyanoacetates to maleimides
    作者:Jin-Jia Wang、Xue-Jiao Dong、Wen-Tao Wei、Ming Yan
    DOI:10.1016/j.tetasy.2011.04.009
    日期:2011.3
    The asymmetric conjugate addition of α-substituted cyanoacetates to N-substituted maleimides has been developed. A number of cinchona alkaloids and amine thioureas were evaluated as catalysts. Takemoto’s catalyst was found to be the most efficient for the transformation. Chiral succinimides with two adjacent quaternary and tertiary stereogenic carbon centers were obtained in good yields, enantioselectivities
    已经开发出α-取代的氰基乙酸酯向N-取代的马来酰亚胺的不对称共轭加成。评价了许多金鸡纳生物碱和胺硫脲作为催化剂。竹本的催化剂被发现是最有效的转化方法。以良好的收率,对映选择性和非对映选择性获得具有两个相邻的季铵和叔立体碳中心的手性琥珀酰亚胺。将产物方便地转化为手性γ-内酰胺,而对映选择性没有损失。
  • Phase‐Transfer Catalytic Strategy: Rapid Synthesis of Spiro‐Fused Heterocycles, Integrated with Four Pharmacophores‐Succinimide, Pyrrolidine, Oxindole, and Trifluoromethyl Group
    作者:Zheng‐Jun Chen、Wei Liang、Zhuo Chen、Lin Chen
    DOI:10.1002/ejoc.202001409
    日期:2021.2.5
    A phase‐transfer catalytic 1,3‐dipolar [3+2] cycloaddition grants rapid generation of various trifluoromethyl spiro‐fused[succinimide‐pyrrolidine‐oxindole]s that might be of great utility for drug discovery. The gram‐scale reaction in conjunction with the derivatizations of the product demonstrate the synthetic potential of this methodology. The reaction mechanism is also discussed.
    相转移催化的1,3-偶极[3 + 2]环加成反应可快速生成各种三氟甲基螺旋稠合的[琥珀酰亚胺-吡咯烷-氧吲哚],这些化合物可能对药物发现有很大的帮助。克级反应以及产物的衍生化证明了该方法的合成潜力。还讨论了反应机理。
查看更多

同类化合物

颜料红254 颜料橙73 颜料橙 71 赛拉霉素 裂假丝菌素 苯扎托品氢溴酸盐 苯乙醇,2-(甲氧基甲基)-(9CI) 细交链孢菌酮酸 禾大壮 甲基4-甲酰基-2,3-二氢-1H-吡咯-1-羧酸酯 甲基4-甲氧基-2,5-二氧代-2,5-二氢-1H-吡咯-3-羧酸酯 甲基3,4-二溴-2,5-二氧代-2H-吡咯-1(5H)-羧酸叔丁酯 甲基2-氮杂双环[3.2.0]庚-3,6-二烯-2-羧酸酯 甲基1-甲基-2,5-二氢-1H-吡咯-3-羧酸酯 甲基(3R)-3-羟基-3,4-二氢-2H-吡咯-5-羧酸酯 烯丙基2,3-二氢-1H-吡咯-1-羧酸酯 氯化烯丙基(3-氯-2-羟基丙基)二甲基铵 氨基甲酰基-2,2,5,5-四甲基-3-吡咯啉-1-氧基 氟酰亚胺 异丙基3,4-二氢-2H-吡咯-5-羧酸酯 己二酸,聚合1,3-二异氰酸基甲基苯,1,2-乙二醇,甲基噁丙环并,噁丙环和1,2-丙二醇 四琥珀酰亚胺金(3+)钾盐 四丁基铵琥珀酰亚胺 吡啶氧杂胺 吡啶,2-[4-(4-氟苯基)-3,4-二氢-2H-吡咯-5-基]- 吡咯烷-2,4-二酮 吡咯布洛芬 叔丁基4-溴-2-氧代-2,5-二氢-1H-吡咯-1-甲酸叔丁酯 叔丁基1H,2H,3H,4H,5H,6H-吡咯并[3,4-C]吡咯-2-甲酸酯盐酸盐 叔-丁基4-(4-氯苯基)-2-氧亚基-2,5-二氢-1H-吡咯-1-甲酸基酯 利收 假白榄内酰胺 二氯马来酸的N-(间甲基苯基)酰亚胺 二-硫代-二(N-苯基马来酰亚胺) 乙基4-羟基-1-[(4-甲氧苯基)甲基]-5-羰基-2-(3-吡啶基)-2H-吡咯-3-羧酸酯 乙基2-氧代-3,4-二氢-2H-吡咯-5-羧酸酯 乙基2,5-二氢-1H-吡咯-3-羧酸酯 乙基1-苄基-4-羟基-5-氧代-2,5-二氢-1H-吡咯-3-羧酸酯 β.-核-六吡喃糖,1,6-脱水-2-O-(2-氰基苯基)甲基-3-脱氧-4-O-甲基- [4-(2,5-二氧代吡咯-1-基)苯基]乙酸酯 [3-乙酰基-2-(4-氟-苯基)-4-羟基-5-氧代-2,5-二氢-吡咯-1-基]-乙酸 [3-(甲氧羰基)-2,2,5,5-四甲基-2,5-二氢-1H-吡咯-1-基]氧氮自由基 [3,4-二(溴甲基)-2,2,5,5-四甲基-2,5-二氢-1H-吡咯-1-基]氧氮自由基 [(2R)-1-乙酰基-2,5-二氢-1H-吡咯-2-基]乙腈 S,S'-[(1-羟基-2,2,5,5-四甲基-2,5-二氢-1H-吡咯-3,4-二基)二(亚甲基)]二甲烷硫代磺酸酯 N-重氮基-4-(2,5-二氧代吡咯-1-基)苯磺酰胺 N-苯基马来酰亚胺 N-甲氧基羰基顺丁烯二酰亚胺 N-甲基-4-羟基-5-氧代-3-吡咯啉-3-羧酸乙酯铁螯合物 N-氨基甲酰马来酰亚胺